Ristic-Fira A - Search Results

1

Evaluation of early radiation DNA damage in a fractal cell nucleus model using Geant4-DNA.

Sakata D, Lampe N, Karamitros M, Kyriakou I, Belov O, Bernal MA, Bolst D, Bordage MC, Breton V, Brown JMC, Francis Z, Ivanchenko V, Meylan S, Murakami K, Okada S, Petrovic I, Ristic-Fira A, Santin G, Sarramia D, Sasaki T, Shin WG, Tang N, Tran HN, Villagrasa C, Emfietzoglou D, Nieminen P, Guatelli S, Incerti S. Sakata D, et al. Among authors: ristic fira a. Phys Med. 2019 Jun;62:152-157. doi: 10.1016/j.ejmp.2019.04.010. Epub 2019 May 17. Phys Med. 2019. PMID: 31109825

2

Radiobiological analysis of human melanoma cells on the 62 MeV CATANA proton beam.

Petrović I, Ristić-Fira A, Todorović D, Valastro L, Cirrone P, Cuttone G. Petrović I, et al. Int J Radiat Biol. 2006 Apr;82(4):251-65. doi: 10.1080/09553000600669859. Int J Radiat Biol. 2006. PMID: 16690593

3

Viability of a human melanoma cell after single and combined treatment with fotemustine, dacarbazine, and proton irradiation.

Petrović IM, Korićanac LB, Todorović DV, Ristić-Fira AM, Valastro LM, Privitera G, Cuttone G. Petrović IM, et al. Ann N Y Acad Sci. 2007 Jan;1095:154-64. doi: 10.1196/annals.1397.019. Ann N Y Acad Sci. 2007. PMID: 17404028

4

Response of a human melanoma cell line to low and high ionizing radiation.

Ristic-Fira AM, Todorovic DV, Koricanac LB, Petrovic IM, Valastro LM, Cirrone PG, Raffaele L, Cuttone G. Ristic-Fira AM, et al. Ann N Y Acad Sci. 2007 Jan;1095:165-74. doi: 10.1196/annals.1397.020. Ann N Y Acad Sci. 2007. PMID: 17404029

5

Assessment of the inhibitory effects of different radiation qualities or chemotherapeutic agents on a human melanoma cell line.

Ristić-Fira AM, Petrović IM, Korićanac LB, Valastro LM, Privitera G, Cuttone G. Ristić-Fira AM, et al. Phys Med. 2008 Dec;24(4):187-95. doi: 10.1016/j.ejmp.2008.04.002. Epub 2008 Jun 2. Phys Med. 2008. PMID: 18514560

6

Early effects of gamma rays and protons on human melanoma cell viability and morphology.

Todorović D, Petrović I, Todorović M, Cuttone G, Ristić-Fira A. Todorović D, et al. J Microsc. 2008 Dec;232(3):517-21. doi: 10.1111/j.1365-2818.2008.02151.x. J Microsc. 2008. PMID: 19094032

7

Effects of fotemustine or dacarbasine on a melanoma cell line pretreated with therapeutic proton irradiation.

Ristić-Fira AM, Korićanac LB, Zakula JJ, Valastro LM, Iannolo G, Privitera G, Cuttone G, Petrović IM. Ristić-Fira AM, et al. J Exp Clin Cancer Res. 2009 Apr 9;28(1):50. doi: 10.1186/1756-9966-28-50. J Exp Clin Cancer Res. 2009. PMID: 19358719 Free PMC article.

8

Anti-tumour activity of fotemustine and protons in combination with bevacizumab.

Korićanac LB, Zakula JJ, Petrović IM, Valastro LM, Cirrone GA, Cuttone G, Ristić-Fira AM. Korićanac LB, et al. Chemotherapy. 2010;56(3):214-22. doi: 10.1159/000316333. Epub 2010 Jun 11. Chemotherapy. 2010. PMID: 20551638

9

Response of a radioresistant human melanoma cell line along the proton spread-out Bragg peak.

Petrović I, Ristić-Fira A, Todorović D, Korićanac L, Valastro L, Cirrone P, Cuttone G. Petrović I, et al. Int J Radiat Biol. 2010 Sep;86(9):742-51. doi: 10.3109/09553002.2010.481322. Int J Radiat Biol. 2010. PMID: 20597839

10

Proton inactivation of melanoma cells enhanced by fotemustine.

Ristić-Fira A, Korićanac L, Žakula J, Keta O, Iannolo G, Cuttone G, Petrović I. Ristić-Fira A, et al. Radiat Prot Dosimetry. 2011 Feb;143(2-4):503-7. doi: 10.1093/rpd/ncq527. Epub 2010 Dec 23. Radiat Prot Dosimetry. 2011. PMID: 21183545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page